PMI U.S. Expands ZYN Portfolio to Offer Adults More Smoke-Free Choices
Article excerpt
Broader range of strengths, flavors, and formats is designed to help legal-age adult nicotine consumers find an option that fits their preferences STAMFORD, Conn., Sept. 9, 2026 /PRNewswire/ -- The U.S. businesses of Philip Morris International (PMI U.S.) today highlighted the continued expansion of the ZYN portfolio, giving legal-age adult nicotine consumers a broader range of smoke-free options across nicotine strengths, flavors, moisture levels, and pouch formats. The portfolio includes the flagship ZYN dry pouch lineup, now expanding to include 1.5 mg and 8 mg strengths, and ZYN ULTRA, an oral nicotine pouch with higher moisture content that, like ZYN, is free of tobacco leaf. Together, these products recognize that preferences are not one-size-fits-all: Legal-age adults looking to switch from cigarettes or other nicotine products should be provided with options, including a range of different nicotine levels, flavor profiles, and formats. Individual preferences can vary based on a range of factors, including the type of tobacco or nicotine product the adult is transitioning away from. "Forty-five million legal-age Americans use nicotine. PMI U.S. is committed to expanding our range of less harmful smoke-free products so that no adult ever smokes another cigarette because they can't find a suitable alternative," said Stacey Kennedy, CEO of PMI U.S. "Consumer choice...
Keep reading with a free account
The rest of this article, and every signal for Philip Morris, is in your free account.
Extracted from this sentence
Building on those milestones, PMI U.S. is expanding its flagship ZYN dry pouch lineup to include 1.5 mg and 8 mg options, in addition to the current 3 mg and 6 mg strengths.
